Well Lead Medical Co., Ltd. (SHA:603309)

Well Lead Medical Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	1,611	1,480	1,366	1,354	1,106	1,121
Other Revenue	29.52	29.52	21.97	9.63	12.68	9.89
Revenue	1,640	1,509	1,388	1,363	1,119	1,131
Revenue Growth (YoY)	11.49%	8.76%	1.79%	21.88%	-1.07%	13.77%
Cost of Revenue	925.99	846.46	762.64	784.98	646.82	637.18
Gross Profit	714.09	662.88	625.1	578.37	471.76	493.49
Selling, General & Admin	285.94	288.14	292.06	286.47	255.91	204.08
Research & Development	115.56	111.11	94.92	82.07	55.03	55.31
Other Operating Expenses	11.4	8.52	2.91	14.09	10.83	11.95
Operating Expenses	413.4	407.98	390.68	381.24	322.6	273.12
Operating Income	300.69	254.9	234.42	197.13	149.16	220.37
Interest Expense	-15.54	-12.32	-9.12	-7.87	-8.49	-10.43
Interest & Investment Income	8.74	12.32	12.2	7.53	1.38	0.9
Currency Exchange Gain (Loss)	5.07	5.07	0.91	7.4	-1.64	-8.24
Other Non Operating Income (Expenses)	-1.85	-0.34	0.26	-1.4	-1.47	-0.68
EBT Excluding Unusual Items	297.11	259.64	238.67	202.79	138.94	201.92
Gain (Loss) on Sale of Investments	1.55	0.62	0.08	1.94	-4.84	-1.79
Gain (Loss) on Sale of Assets	0.26	0.43	0.09	-0.07	0	-2.58
Asset Writedown	-3.83	-1.34	-0.46	-7.47	-0.56	-9.79
Other Unusual Items	3.7	3.7	-1.08	8.46	6.69	2.35
Pretax Income	298.79	263.04	237.3	205.65	140.22	190.11
Income Tax Expense	42.72	34.57	32.7	27.9	25.55	30.23
Earnings From Continuing Operations	256.07	228.47	204.6	177.75	114.67	159.88
Minority Interest in Earnings	-11.76	-9.08	-12.12	-11.18	-8.58	-6.77
Net Income	244.31	219.39	192.49	166.57	106.09	153.11
Net Income to Common	244.31	219.39	192.49	166.57	106.09	153.11
Net Income Growth	13.48%	13.98%	15.56%	57.00%	-30.71%	26.39%
Shares Outstanding (Basic)	294	293	292	292	259	260
Shares Outstanding (Diluted)	294	293	292	292	259	260
Shares Change (YoY)	1.22%	0.30%	-0.20%	12.93%	-0.29%	0.68%
EPS (Basic)	0.83	0.75	0.66	0.57	0.41	0.59
EPS (Diluted)	0.83	0.75	0.66	0.57	0.41	0.59
EPS Growth	12.11%	13.64%	15.79%	39.02%	-30.51%	25.53%
Free Cash Flow	98.99	-9.47	-135.38	209.75	78	135.96
Free Cash Flow Per Share	0.34	-0.03	-0.46	0.72	0.30	0.52
Dividend Per Share	0.700	0.500	0.500	0.340	0.135	0.200
Dividend Growth	40.00%	-	47.06%	151.85%	-32.50%	30.04%
Gross Margin	43.54%	43.92%	45.04%	42.42%	42.18%	43.65%
Operating Margin	18.33%	16.89%	16.89%	14.46%	13.33%	19.49%
Profit Margin	14.90%	14.54%	13.87%	12.22%	9.49%	13.54%
Free Cash Flow Margin	6.04%	-0.63%	-9.75%	15.38%	6.97%	12.02%
EBITDA	362.52	317.3	297.58	253.46	198.48	268.92
EBITDA Margin	22.10%	21.02%	21.44%	18.59%	17.74%	23.78%
D&A For EBITDA	61.83	62.4	63.16	56.33	49.32	48.55
EBIT	300.69	254.9	234.42	197.13	149.16	220.37
EBIT Margin	18.33%	16.89%	16.89%	14.46%	13.33%	19.49%
Effective Tax Rate	14.30%	13.14%	13.78%	13.57%	18.22%	15.90%
Revenue as Reported	1,640	1,509	1,388	1,363	1,119	1,131

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.